Alnylam Keeps Making New Strides In RNAi Research

Alnylam posts positive phase 2 results in open-label study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.